Vice President, US National Sales

About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Overview of Role: The VP of US National Sales will lead the field launch of ivonescimab. The successful candidate will be responsible for developing and executing a national sales strategy, managing sales team performance, recruiting and training top field leaders and representatives, and ensuring effective field launch execution. This role also involves maintaining a feedback loop from the field, organizing sales meetings, determining sales force sizing and structure, developing sales training strategies, and representing the sales team in senior leadership and strategic planning discussions. This role will report into the Chief Commercial Officer. Role and Responsibilities: Develop and implement comprehensive national sales strategies across teams to drive market penetration and achieve sales targets. This includes analyzing market trends, competitive landscape, and customer & account needs to inform strategic decisions. Monitor and evaluate sales team performance, setting clear objectives, and KPIs to ensure alignment with business goals. Provide ongoing coaching and support to maximize individual and team performance. Recruit, train, and retain top field leaders and representatives, fostering a high-performance culture. Develop and implement training programs to enhance product knowledge, sales skills, and compliance with industry regulations. Lead field launch execution, ensuring that sales teams are well-prepared and equipped to effectively promote new oncology products. Coordinate with marketing, market access, operations, and medical affairs to ensure cohesive launch strategies. Establish a robust feedback loop from the field to gather insights and inform continuous improvement of sales strategies and tactics. Regularly communicate with field teams to understand challenges and opportunities. Plan and conduct regular sales meetings to align teams on strategy, share best practices, and address any issues. Foster a collaborative environment to encourage knowledge sharing and innovation. Determine optimal…